Edition:
India

NuVasive Inc (NUVA.OQ)

NUVA.OQ on NASDAQ Stock Exchange Global Select Market

53.61USD
20 Jul 2018
Change (% chg)

-- (--)
Prev Close
$53.61
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
211,343
52-wk High
$81.48
52-wk Low
$44.62

Chart for

About

Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal... (more)

Overall

Beta: 0.79
Market Cap(Mil.): $2,893.28
Shares Outstanding(Mil.): 50.80
Dividend: --
Yield (%): --

Financials

BRIEF-NuVasive Reports Q1 GAAP Loss Per Share Of $0.53

* FY2018 REVENUE VIEW $1.10 BILLION -- THOMSON REUTERS I/B/E/S

02 May 2018

BRIEF-Nuvasive Posts Q4 Adj. Earnings Per Share $0.56

* NUVASIVE REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

27 Feb 2018

BRIEF-John DeFord To Join NuVasive Board Of Directors

* NUVASIVE INC - AS A RESULT OF DEFORD'S APPOINTMENT, NUVASIVE BOARD OF DIRECTORS CONSISTS OF 10 DIRECTORS Source text for Eikon: Further company coverage:

09 Feb 2018

Earnings vs. Estimates